These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1290 related items for PubMed ID: 17531124

  • 21. Detection of genomic mutations in katG, inhA and rpoB genes of Mycobacterium tuberculosis isolates using polymerase chain reaction and multiplex allele-specific polymerase chain reaction.
    Khosravi AD, Goodarzi H, Alavi SM.
    Braz J Infect Dis; 2012; 16(1):57-62. PubMed ID: 22358357
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico.
    Viader-Salvadó JM, Luna-Aguirre CM, Reyes-Ruiz JM, Valdez-Leal R, del Bosque-Moncayo Mde L, Tijerina-Menchaca R, Guerrero-Olazarán M.
    Microb Drug Resist; 2003; 9(1):33-8. PubMed ID: 12705681
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effective pragmatic approach of diagnosis of multidrug-resistant tuberculosis by high-resolution melt curve assay.
    Negi SS, Singh P, Bhargava A, Chandrakar S, Gaikwad U, Das P, Behra A.
    Int J Mycobacteriol; 2018; 7(3):228-235. PubMed ID: 30198501
    [Abstract] [Full Text] [Related]

  • 27. Study of rifampicin and isoniazid resistance mutation genes of M. tuberculosis isolates in Nepal.
    Khadka JB, Rai SK, Shrestha S, Maharjan B, Bhatta DR, Ghimire P.
    Nepal Med Coll J; 2011 Sep; 13(3):147-51. PubMed ID: 22808802
    [Abstract] [Full Text] [Related]

  • 28. Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
    Sharma S, Madan M, Agrawal C, Asthana AK.
    Indian J Pathol Microbiol; 2014 Sep; 57(3):423-6. PubMed ID: 25118735
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM, Ahmad S, Mokaddas E, Eldeen HS, Joseph S.
    BMC Infect Dis; 2019 Jan 03; 19(1):3. PubMed ID: 30606116
    [Abstract] [Full Text] [Related]

  • 32. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates in Guangdong, China.
    Wang YC, Zhu RY, Xu YY, Zhao MQ, Liu YH, Li B, Chen JD.
    Jpn J Infect Dis; 2009 Jul 03; 62(4):270-4. PubMed ID: 19628903
    [Abstract] [Full Text] [Related]

  • 33. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays.
    Aragón LM, Navarro F, Heiser V, Garrigó M, Español M, Coll P.
    J Antimicrob Chemother; 2006 May 03; 57(5):825-31. PubMed ID: 16547071
    [Abstract] [Full Text] [Related]

  • 34. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
    Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC.
    BMC Infect Dis; 2012 Feb 10; 12():37. PubMed ID: 22325147
    [Abstract] [Full Text] [Related]

  • 35. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
    Nikolayevsky V, Brown T, Balabanova Y, Ruddy M, Fedorin I, Drobniewski F.
    J Clin Microbiol; 2004 Oct 10; 42(10):4498-502. PubMed ID: 15472300
    [Abstract] [Full Text] [Related]

  • 36. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia.
    Lavender C, Globan M, Sievers A, Billman-Jacobe H, Fyfe J.
    Antimicrob Agents Chemother; 2005 Oct 10; 49(10):4068-74. PubMed ID: 16189082
    [Abstract] [Full Text] [Related]

  • 37. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.
    Mokrousov I, Bhanu NV, Suffys PN, Kadival GV, Yap SF, Cho SN, Jordaan AM, Narvskaya O, Singh UB, Gomes HM, Lee H, Kulkarni SP, Lim KC, Khan BK, van Soolingen D, Victor TC, Schouls LM.
    J Microbiol Methods; 2004 Jun 10; 57(3):323-35. PubMed ID: 15134881
    [Abstract] [Full Text] [Related]

  • 38. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam.
    Caws M, Duy PM, Tho DQ, Lan NT, Hoa DV, Farrar J.
    J Clin Microbiol; 2006 Jul 10; 44(7):2333-7. PubMed ID: 16825345
    [Abstract] [Full Text] [Related]

  • 39. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system].
    Isakova ZhT.
    Georgian Med News; 2008 May 10; (158):15-9. PubMed ID: 18560033
    [Abstract] [Full Text] [Related]

  • 40. Molecular characterization of drug-resistant mycobacterium tuberculosis isolates from Sichuan Province in china.
    Guo JH, Xiang WL, Zhao QR, Luo T, Huang M, Zhang J, Zhao J, Yang ZR, Sun Q.
    Jpn J Infect Dis; 2008 Jul 10; 61(4):264-8. PubMed ID: 18653966
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.